GBI eNews

Please add 11cabfa9709432e9918fd20a96d9deb8@lists.pharmasentry.com to your e-mail address book to ensure you receive our eNews

November 17, 2011

Sign-up for this newsletter | Opt-out of this newsletter | E-mail to a Colleague

News Update

Click Title for complete article or click Summary for overview of each article.

New flu shot is less of a pain [Times Union, Albany, N.Y.]
From Times Union (Albany, NY) - Nov 14, 2011
Nov. 14-- This year's flu shot may hurt a little less. Needle haters "are happy they don't have to have that big needle going into their muscle," said Athena Coloma, a nurse who gives the shot at Albany Medical's Latham Medical/Pediatrics office. The flu season is just starting in New York.
[ Summary ]

Technology advances ease personal diabetes care [The Miami Herald]
From Miami Herald (FL) - Nov 14, 2011
It is therefore important that consumers be mindful and research what is available and ensure that all major diabetes management decisions are discussed with the individual's health care team, "said Kellie Rodriguez, director of education services at the Diabetes Research Institute, University of Miami.
[ Summary ]

Genomics and Biotechnology

Click Title for complete article or click Summary for overview of each article.

Mesoblast's Stem Cell Therapy Works in Phase II HF Trial
From BioWorld Insight - Nov 15, 2011
LONDONâ?? Mesoblast Ltd. has revived hopes for the potential use of stem cells to treat heart disease, delivering positive results in a 60- patient Phase II trial of Revascor in congestive heart failure, and significantly for the allogeneic cell therapy, reporting the product did not provoke any adverse immune responses.
[ Summary ]

Geron halts human stem cell research trial
From UPI Science News - Nov 15, 2011
The U.S. Food and Drug Administration granted approval to Geron Corp. last year to conduct the world's first clinical trial of a human embryonic stem cell therapy in humans. The study, which is currently in Phase 1, is being ended for financial reasons, Geron said Monday.
[ Summary ]

FDA: New Treatments

Click Title for complete article or click Summary for overview of each article.

FDA Approves First Drug to Treat a Rare Bone Marrow Disease
From Targeted News Service - Nov 17, 2011
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release:. The U.S. Food and Drug Administration today approved Jakafi, the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis.
[ Summary ]

FDA panel backs Pfizer vaccine for adults
From Associated Press - Nov 16, 2011
The Food and Drug Administration's vaccine panel voted 14-1 that data supports Pfizer's Prevnar 13 as a safe and effective vaccine for preventing the bacterial infection in adults. But the disease also affects 36,000 older adults per year, killing 5,000 of them, according to the latest figures from the Centers for Disease Control and Prevention.
[ Summary ]

Oncology

Click Title for complete article or click Summary for overview of each article.

Novel Monoclonal Antibody Offers Potential Treatment for Tumors Resistant to VEGF Therapy
From Targeted News Service - Nov 15, 2011
Now, a study reported at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics suggests that targeting a novel antiangiogenic receptor may help patients whose cancer does not respond to existing agents.
[ Summary ]

ALK Inhibition New Target in Inflammatory Breast Cancer
From BioWorld Today - Nov 14, 2011
One famous example is the writer Christopher Hitchens, who is being treated with chronic myelogenous leukemia drug Gleevec for esophageal cancer.
[ Summary ]

Emerging Medical Technologies

Click Title for complete article or click Summary for overview of each article.

SterilMed Names Mike Gustafson Company President; Company to expand access to cost-effective reprocessed single-use medical device alternatives
From ENP Newswire - Nov 07, 2011
Release date- 04112011- Maple Grove, MN- SterilMed, Inc., a leader in the reprocessing and remanufacturing of single use medical devices, today announced the appointment of Mike Gustafson as Company President. This announcement comes as Ethicon Endo-Surgery, Inc. announced in a separate news release the closing of its transaction to acquire SterilMed.
[ Summary ]

Education

CLICK THE FOLLOWING TITLES TO PARTICIPATE IN THE ONLINE CME/CEU

Therapeutic Update in Hepatic Encephalopathy and Management Decisions
- Supported by an educational grant from Salix Pharmaceuticals

Lessons Learned from Fibromyalgia
- Supported by an educational grant from Forest Laboratories and Pfizer Inc.

Considering Treatment Options in Advanced Non-Small Cell Lung Cancer
- Supported by an educational grant from Genentech BioOncology/OSI Oncology

Journal of Managed Care Medicine

Your Logo Here

Journal of Managed Care Medicine Vol 14, Issue 4 Table of Contents

You can click here to visit our main journal page and click on each individual article below to visit their article page and then download the PDF! If you are interested in advertiseing in JMCM, please contact Sloane Reed at sreed@namcp.org or 804-527-1905. Contact Jeremy Williams at 804-527-1905 if you are interested in submitting an article.

Click here to visit the Journal of Managed Care Medicine website and view the the journal in its digital format.

Antidepressants in primary care: is this any way to treat depression?

Antidepressants, now the third-most commonly prescribed class of drugs in the United States, are routinely offered to patients with vague complaints of fatigue, pain and malaise but who are not classified as suffering from a mental disorder by the physician who recommends the treatment, says a new study. And among primary care provider as well as specialists who are not psychiatrists, the practice of prescribing these medications without diagnosing depression is rising steeply, the study finds.

If you are interested in reading the entire article, please click here.

Join NAMCP's LinkedIn Group!

This is a GREAT way to network with other members, send them direct messages, post comments or questions and learn more about your colleagues working in other areas of managed care! If you are a member of this professional, social network, please click here to visit our group home page!

Join AAMCN's LinkedIn Group!

Visit NAMCP's Career Center!

To find a job or fill a position, visit http://careers.namcp.org. You can also click on the links following each individual job below to be taken to their new page on our career center.

Job seekers and employers have discovered the advantages of searching online for the best jobs and for qualified candidates to fill them. But, the mass-market approach of the mega job boards may not be your best avenue.

NAMCP's Career Center gives employers and job seeking managed care professionals a better way to find one another and make that perfect career fit.

For Job Seekers: Post your resume; Search job listings; Set up Search Agents; and have new postings sent to you via email.

For Employers: Post your jobs; Target a focused audience of candidates; Search resumes; Track applications; Promote your company online.

If you have an available position or have an interest in our placement service, please contact David Mara at (804)527-1905 or e-mail at dmara@namcp.org.

Genomics Biotech Institute eNews for November 17, 2011

Produced by NAMCP & Genomics Biotech Institute
4435 Waterfront Drive, Suite 101
Glen Allen, VA 23060
Telephone: 804-527-1905
Fax: 804-747-5316

Click "Opt-out of this newsletter" at the top of the newsletter or contact Jeremy Williams at jwilliams@namcp.org or 804-527-1905 to be taken off the list

NAMCP 20th Anniversary!

Join NAMCP in celebrating 20 years of improving patient outcomes!

Contact Us!

If you have any questions, or need to contact someone with the Genomics Biotech and Emerging Medical Technology eNews or GBEMTI staff, please click on the following website, enter your contact information and comment/question, and we will back with you shortly.

CLICK HERE to visit our contact page

NAMCP Medical Directors Resource Centers

The purpose of NAMCP's Medical Directors Resource Centers is to provide Medical Directors with access to disease specific information and resources and to improve patient outcomes.

Accessing NAMCP's Medical Directors Resource Centers will allow you to:

Use screening tools to diagnose

Access treatment and best practice guidelines

Improve patient adherence and compliance

Improve patient outcomes

Better manage patients

Review cost of treatment versus overall economic burden

Provide resources for your network physicians

Provide resources for patients

CLICK HERE to access the Hypertension Resource Center

CLICK HERE to access the Depression Resource Center

CLICK HERE to access the COPD Resource Center

CLICK HERE to access the Fibromyalgia Resource Center

CLICK HERE to access the Hyperlipidemia Resource Center

CLICK HERE to access the Bipolar Resource Center

CLICK HERE to access the Obesity Resource Center

CLICK HERE to access the Sleep Resource Center

CLICK HERE to access the Diabetes Resource Center

CME on the Web

Click each to view

Optimizing the Prevention and Treatment of Venous Thromboembolism

What's New in the Pharmacological Management of Prostate Cancer

Targeted Molecular Therapy for Renal Cell Carcinoma: Impact on Existing Treatment Paradigms

Management and Treatment of Cancer Patients with Chemotherapy Induced Nausea and Vomiting

NAMCP Behavioral Health Resource Center

Preventative Behavioral Health Treatment: Stress and Medical Illness

New studies are proving how inextricably linked stress is to physical health. Stress may be affecting your patient's health in more ways than you think. Discover the latest links between stress and serious illness. For more info please click here.

If you are interested in the NAMCP Behavioral Health Resource Center, please contact Katie Eads at 804-527-1905 or keads@namcp.org.

GENOMICS BIOTECH INSTITUTE

Click each to view

Join GBI

Become a Corporate Member

Learn more at www.genomics-biotech.org

NAMCP INFORMATION

Click each to view

Join NAMCP

Medical Directors Insitute

Health Management Institute

Become a Corporate Member

Learn more at www.namcp.org

For More Information Contact:

Publisher:
Jeremy Williams, jwilliams@namcp.org or 804-527-1905

Advertising Sales:
Sloane Reed, sreed@namcp.org or 804-527-1905


	Powered By: